F&S science · 2026
Hyaluronan-enriched transfer medium increases live birth rates in biopsied euploid blastocyst transfers.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Stansbury Nicholas, Toro Diana, Barnett Natalie, Alsaidi Amir, Collins Hannah, Thompson Jim, Said Al-Hasen, Reed Michael
Аннотация
OBJECTIVE: To evaluate whether hyaluronan-enriched transfer medium (HETM) is associated with improved live birth rates in biopsied euploid blastocyst transfers.
DESIGN: Retrospective cohort study.
SUBJECTS: A total of 1,221 single frozen euploid blastocyst transfers performed between January 2011 and December 2024.
EXPOSURE: Embryo transfer using HETM compared with standard zwitterionic-buffered transfer medium. All embryos underwent trophectoderm biopsy.
MAIN OUTCOME MEASURES: Live birth rate. Secondary outcomes included biochemical pregnancy and clinical pregnancy rates.
RESULTS: Hyaluronan-enriched transfer medium was associated with significantly higher live birth rates compared with standard medium (59.1% vs. 43.2%; absolute difference 15.9%, 95% confidence interval 10.3%-21.5%; relative risk 1.37, 95% confidence interval 1.22-1.54). Clinical pregnancy and biochemical pregnancy rates were also significantly higher in the hyaluronan group. Sensitivity analysis restricted to first transfers per patient (n = 715) confirmed persistence of the live birth benefit (61.2% vs. 47.1%; absolute difference 14.1%, 95% confidence interval 6.9%-21.3%; relative risk 1.30, 95% confidence interval 1.13-1.49). Maternal age was comparable between groups.
CONCLUSION: Use of HETM is associated with a clinically meaningful increase in live birth rates in biopsied euploid blastocyst transfers. Zona pellucida disruption created during trophectoderm biopsy may facilitate enhanced embryo-endometrial interaction, improving implantation efficiency. However, these results should be interpreted with caution, given the potential for unmeasured confounding variables and require validation in prospective randomized trials.
DESIGN: Retrospective cohort study.
SUBJECTS: A total of 1,221 single frozen euploid blastocyst transfers performed between January 2011 and December 2024.
EXPOSURE: Embryo transfer using HETM compared with standard zwitterionic-buffered transfer medium. All embryos underwent trophectoderm biopsy.
MAIN OUTCOME MEASURES: Live birth rate. Secondary outcomes included biochemical pregnancy and clinical pregnancy rates.
RESULTS: Hyaluronan-enriched transfer medium was associated with significantly higher live birth rates compared with standard medium (59.1% vs. 43.2%; absolute difference 15.9%, 95% confidence interval 10.3%-21.5%; relative risk 1.37, 95% confidence interval 1.22-1.54). Clinical pregnancy and biochemical pregnancy rates were also significantly higher in the hyaluronan group. Sensitivity analysis restricted to first transfers per patient (n = 715) confirmed persistence of the live birth benefit (61.2% vs. 47.1%; absolute difference 14.1%, 95% confidence interval 6.9%-21.3%; relative risk 1.30, 95% confidence interval 1.13-1.49). Maternal age was comparable between groups.
CONCLUSION: Use of HETM is associated with a clinically meaningful increase in live birth rates in biopsied euploid blastocyst transfers. Zona pellucida disruption created during trophectoderm biopsy may facilitate enhanced embryo-endometrial interaction, improving implantation efficiency. However, these results should be interpreted with caution, given the potential for unmeasured confounding variables and require validation in prospective randomized trials.